Back to search

Article

Ligand-receptor pair-based signature score Derived from On-treatment Tumor Specimens Predicts Immune Checkpoint Blockade Response in Metastatic Melanoma

2025-04-17

Abstract excerpt

<title>Abstract</title> <p>Immune checkpoint blockade (ICB) therapy has transformed the treatment landscape for metastatic melanoma, yet predicting therapeutic response remains a significant challenge. This study hypothesizes that coordinated ligand-receptor (LR) interactions within the tumor microenvironment (TME) critically influence ICB efficacy and proposes that a novel LR pair-based signature score (LRPS) de...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
72b10b05-6265-5e37-8db2-ea7f9ed8669a
DOI
10.21203/rs.3.rs-5854916/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ligand-receptor pair-based signature score Derived from On-treatment Tumor Specimens Predicts Immune Checkpoint Blockade Response in Metastatic MelanomaDOI 10.21203/rs.3.rs-5854916/v1
Select a neighboring publication to make it the new centre.